Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Unpacking rare diseases in the first edition of Delta magazine

March 26, 2021 | COVID-19, Medical Communications, commercial, consulting, coronavirus, creative, med comms, patient engagement, patient experience, rare disease 

Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization.

- PMLiVE

Welcome to Delta – the new Fishawack Health magazine.

We’ve chosen to focus our first edition of the magazine on a topic close to our hearts, rare diseases.

Rare diseases represent an incredibly high unmet need, not only due to the lack of therapies and the practical difficulties in diagnosis, but also in patients’ desire for better knowledge, communication, and more meaningful relationships with their healthcare professionals.

As our rare disease specialist agency Dudnyk says: “We are seeing a growing separation between healthcare professionals and patients. The impact of this great divide in understanding is negatively affecting the treatment experience—for both sides—as well as severely limiting the trajectory of specialty healthcare brands.”

The dynamic between patients and healthcare professionals, combined with the challenges of patient identification and data generation in tiny patient populations (made even more challenging in a global pandemic), means rare disease drug development and launch requires a unique business model.

In this edition of Delta, our consultants, creatives and medical communications experts explore the challenges and opportunities for life science companies operating in rare disease, including:

  • Navigating real-world evidence and why it could be a gamechanger in rare disease
  • A patient’s account of living with a rare disease in the COVID-19 pandemic
  • How to make an impact in small patient populations
  • The lessons Dan Zaksas, PhD, Senior Vice President, Director of Scientific and Medical Affairs at Dudnyk, has learned during a decade working in rare diseases
  • Why you need to build relationships with KOLs and patients much earlier than you think
  • The lasting implications of COVID-19 on the life science industry.

DOWNLOAD THE MAGAZINE HERE

This content was provided by Avalere Health

Company Details

- PMLiVE

Avalere Health

Email
Website

 Latest Content from  Avalere Health 

Hepatitis (C)an’t wait: taking a de-centralized approach to cure the epidemic

Hepatitis C is a curable disease, so why are so many countries off track to achieve the World Health Organization elimination target? This World Hepatitis Day, we compare several countries’...

The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor

Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals how life...

Healthcare tech: the driving force behind value-based care?

In 2020, healthcare technology investment went into overdrive. We speak to Sunny Kumar, Partner at GSR Ventures, to find out how COVID‑19 has transformed the industry and whether healthcare technology...

Numbers, navigation, and narratives: digital storytelling in medical communications

Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...

Building the hospital of the future

Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience.

Welcoming analytics-driven digital marketing agency closerlook to the Fishawack Health pack

Fishawack Health enhances its omnichannel capabilities with the acquisition of closerlook, a data analytics and digital native healthcare agency specializing in intelligent omnichannel marketing solutions.

The rise of the healthcare social media influencer

The consumer industry has long been leveraging the power of social media influencers with enormous success. But can the highly regulated healthcare industry achieve the same results? Daniel Brackins explores...

Vaccine hesitancy eBook

In this e-book, we answer the difficult questions around vaccine hesitancy. Our consultants and commercial experts explore the behavioural science and reveal strategies for improving uptake.

Deep 6 AI: the smart software breathing new life into clinical trials

Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention.

Are you ready for the digital health revolution?

In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age.